A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
This study ended early.
Multiple locations, including San Francisco
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study ended early.
Multiple locations, including San FranciscoThis study ended early.
In VancouverA Repeated Dose Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In IchikawaMultiple-dosing Study of Long Acting Injectable of Risperidone in Schizophrenic Patients
This study has finished and is no longer accepting participants.
Location not clearly listedThis study has finished and is no longer accepting participants.
In AustraliaA Comparative Study of the Steady State Pharmacokinetics of Lithium Before and During Multiple Oral Daily Topiramate (RWJ-17021) Dosing in Patients With Bipolar Disorders
This study has finished and is no longer accepting participants.
Location not clearly listedThis study has finished and is no longer accepting participants.
In ShanghaiA Pharmacokinetic Study of MP-214 in Patients With Schizophrenia (12 Weeks Treatment Study)
This study has finished and is no longer accepting participants.
In SakaiA Comparative Study of the Steady-state Pharmacokinetics of Risperidone and Topiramate on Monotherapy and During Combination Therapy in Patients With Bipolar or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedPharmacokinetic Evaluation of the Relative Bioavailability of Three Paliperidone Extended Release (ER) Formulations With Different in Vitro Release Profiles, and Comparison to Paliperidone Immediate Release (IR), in Healthy Male Subjects
This study has finished and is no longer accepting participants.
Location not clearly listedThis study was withdrawn before enrollment.
In BaltimoreThis study has finished and is no longer accepting participants.
In RochesterWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.